Passage BioPASG
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 31 institutions reported holding Passage Bio Inc. (PASG) in their 13F filings, up 29 from Q2 2025. 7 opened new positions and 0 sold out. The largest holders were Lynx1 Capital Management LP ($5.0M), Vestal Point Capital, LP ($2.4M) and Erste Asset Management GmbH ($999K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Passage Bio Inc.
- CUSIP
- 702712209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $191K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 236,721 shares bought and 269,061 shares sold, net −32,340 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Lynx1 Capital Management LP | 1.02% | Add +34.8% | 623,704 | $5.0M |
| Vestal Point Capital, LP | 0.11% | No change | 305,000 | $2.4M |
| Erste Asset Management GmbH | 0.01% | No change | 122,790 | $999K |
| Vanguard Group Inc. | 0.00% | Add +14.7% | 117,030 | $937K |
| Renaissance Technologies | 0.00% | Add +42.3% | 100,789 | $809K |
| Tang Capital Management LLC | 0.02% | No change | 75,000 | $602K |
| Orbimed Advisors LLC | 0.01% | Reduce -80.5% | 59,046 | $474K |
| BlackRock, Inc. | 0.00% | No change | 29,749 | $239K |
| Geode Capital Management, LLC | 0.00% | Add +1.3% | 27,283 | $219K |
| Acadian Asset Management LLC | 0.00% | Reduce -45.2% | 25,568 | $204K |
| Squarepoint Ops LLC | 0.00% | New | 23,500 | $188K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 20,803 | $167K |
| Citadel Advisors | 0.00% | Add +54.2% | 19,091 | $153K |
| Fiduciary Trust Co | 0.00% | No change | 10,750 | $86K |
| Morgan Stanley | 0.00% | Add +3.5% | 338 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -80.3% | 289 | $2K |
| Barclays PLC | 0.00% | Add +0.4% | 212 | $2K |
| MAI Capital Management | 0.00% | New | 200 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -95.1% | 142 | $1K |
| Citigroup Inc. | 0.00% | New | 77 | $617 |
| Bank of America Corp. | 0.00% | Add +11.3% | 28 | $225 |
| Osaic Holdings, Inc. | 0.00% | Reduce -80.0% | 20 | $141 |
| UBS Group AG | 0.00% | Add +11233.3% | 17 | $137 |
| Parallel Advisors, LLC | 0.00% | New | 16 | $128 |
| JPMorgan Chase & Co. | 0.00% | Add +9.9% | 15 | $120 |
| BNP Paribas Financial Markets | 0.00% | Add +6.7% | 12 | $96 |
| LRI Investments, LLC | 0.00% | Reduce -94.7% | 12 | $96 |
| Harbour Investments, Inc. | 0.00% | New | 3 | $24 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 2 | $16 |
| Cwm, LLC | 0.00% | New | 1 | $0 |
| Tsfg, LLC | 0.00% | No change | 5 | $0 |
"% of holder's portfolio" is PASG's weight in each manager's 13F, not the share of Passage Bio Inc. the manager owns.